Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1899 1
1902 1
1948 3
1949 2
1950 2
1951 1
1952 1
1954 1
1955 5
1956 2
1957 3
1958 7
1959 1
1960 4
1961 4
1962 7
1963 5
1964 7
1965 6
1966 12
1967 13
1968 13
1969 8
1970 8
1971 16
1972 8
1973 10
1974 17
1975 11
1976 9
1977 11
1978 23
1979 17
1980 20
1981 17
1982 18
1983 17
1984 12
1985 14
1986 16
1987 22
1988 19
1989 22
1990 17
1991 14
1992 23
1993 17
1994 17
1995 16
1996 18
1997 10
1998 20
1999 9
2000 14
2001 22
2002 20
2003 20
2004 28
2005 15
2006 21
2007 19
2008 24
2009 22
2010 32
2011 33
2012 41
2013 36
2014 36
2015 39
2016 56
2017 52
2018 51
2019 53
2020 42
2021 63
2022 43
2023 43
2024 31

Text availability

Article attribute

Article type

Publication date

Search Results

1,334 results

Results by year

Filters applied: . Clear all
Page 1
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. Page MJ, et al. Among authors: mckenzie je. BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71. BMJ. 2021. PMID: 33782057 Free PMC article.
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews.
Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, McKenzie JE. Page MJ, et al. Among authors: mckenzie je. BMJ. 2021 Mar 29;372:n160. doi: 10.1136/bmj.n160. BMJ. 2021. PMID: 33781993 Free PMC article.
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. Page MJ, et al. Among authors: mckenzie je. PLoS Med. 2021 Mar 29;18(3):e1003583. doi: 10.1371/journal.pmed.1003583. eCollection 2021 Mar. PLoS Med. 2021. PMID: 33780438 Free PMC article.
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. Page MJ, et al. Among authors: mckenzie je. Syst Rev. 2021 Mar 29;10(1):89. doi: 10.1186/s13643-021-01626-4. Syst Rev. 2021. PMID: 33781348 Free PMC article. No abstract available.
Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775.
Makker V, Colombo N, Casado Herráez A, Monk BJ, Mackay H, Santin AD, Miller DS, Moore RG, Baron-Hay S, Ray-Coquard I, Ushijima K, Yonemori K, Kim YM, Guerra Alia EM, Sanli UA, Bird S, Orlowski R, McKenzie J, Okpara C, Barresi G, Lorusso D. Makker V, et al. Among authors: mckenzie j. J Clin Oncol. 2023 Jun 1;41(16):2904-2910. doi: 10.1200/JCO.22.02152. Epub 2023 Apr 14. J Clin Oncol. 2023. PMID: 37058687 Free PMC article. Clinical Trial.
Work-Relatedness.
Greaves WW, Das R, McKenzie JG, Sinclair DC 2nd, Hegmann KT. Greaves WW, et al. Among authors: mckenzie jg. J Occup Environ Med. 2018 Dec;60(12):e640-e646. doi: 10.1097/JOM.0000000000001492. J Occup Environ Med. 2018. PMID: 30475305 No abstract available.
Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study.
Choueiri TK, Eto M, Motzer R, De Giorgi U, Buchler T, Basappa NS, Méndez-Vidal MJ, Tjulandin S, Hoon Park S, Melichar B, Hutson T, Alemany C, McGregor B, Powles T, Grünwald V, Alekseev B, Rha SY, Kopyltsov E, Kapoor A, Alonso Gordoa T, Goh JC, Staehler M, Merchan JR, Xie R, Perini RF, Mody K, McKenzie J, Porta CG. Choueiri TK, et al. Among authors: mckenzie j. Lancet Oncol. 2023 Mar;24(3):228-238. doi: 10.1016/S1470-2045(23)00049-9. Lancet Oncol. 2023. PMID: 36858721 Clinical Trial.
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. Page MJ, et al. Among authors: mckenzie je. J Clin Epidemiol. 2021 Jun;134:178-189. doi: 10.1016/j.jclinepi.2021.03.001. Epub 2021 Mar 29. J Clin Epidemiol. 2021. PMID: 33789819 Free article.
1,334 results